摘要
乳腺癌是女性最常见的恶性肿瘤,也是女性癌症死亡主要的原因,各种治疗方式在提高乳腺癌患者生存率的同时,其心脏毒性也逐渐引起人们的重视。然而近年来也有部分研究发现,抗肿瘤药物并没有显著增加患者心血管疾病的死亡率。就乳腺癌患者心血管系统疾病的研究现状和争议综述,以期为关注这一领域的临床研究者提供一些思路。
The most common malignant tumor in women is breast cancer,which is also the main cause of female cancer death.Various treatment methods have improved the survival rate of breast cancer patients,and their cardiotoxicities have gradually attracted people's attention.Recent studies have found that anti-tumor drugs do not significantly increase the mortality of cardiovascular disease in patients.This article reviewed current status and controversy of cardio-oncology in breast cancer to provide thoughts for clinical researchers in this field.
作者
杨艺琦
吴昊(综述)
殷咏梅(审校)
YANG Yiqi;WU Hao;YIN Yongmei(Nanjing Medical University,Nanjing 210029,Jiangsu Province,China;Department of Oncology,the First Affiliated Hospital of Nanjing Medical University,Nanjing 210029,Jiangsu Province,China)
出处
《中国癌症杂志》
CAS
CSCD
北大核心
2020年第6期475-480,共6页
China Oncology
基金
国家重点研发计划项目(2016YFC0905900)
肿瘤个体化医学协同创新项目(JX21817902/008)。
关键词
乳腺癌
肿瘤心脏病学
心脏毒性
心血管疾病
Breast cancer
Cardio-oncology
Cardiotoxicity
Cardiovascular disease